argyrotsipi/train-dataset huggingface dataset:
Topical Questions — House of Commons, 2018-06-12
Topic: Culture
Gregory David Clark (Conservative, Centre-right): The hon. Lady will concede that the efforts and engagement through the city of culture year between the Government and Hull were very substantial and very effective. I am familiar with the House of Fraser store in Hull. I know what an important part it plays in the life of the town centre. I understand that the council is confident that such a prime site, which I know well, will be taken up. I will work closely with the council to make sure, through the sector council, it has all the help it needs.
Appointment of Sir Roger Scruton — House of Commons, 2018-11-12
Topic: Culture
Edward Vaizey (Conservative, Centre-right): The Opposition never raised a peep when Sir Roger Scruton was appointed as an adviser, nor indeed when he got his knighthood, but they learned from the bully-boy smear tactics that ousted my good friend Toby Young that this kind of smear campaign works. How much more impressive it would be if the Opposition shared my concern about Sir Roger Scruton’s appointment, which is that I do not want him to lead a commission that simply advocates for neo-Georgian pastiche as a definition of beauty. I hope that the commission will include contemporary architects, women and people with BAME backgrounds as well. As far as Sir Roger’s character is concerned, and his views, it is impeccable; he just has a slightly dodgy neo-Georgian pastiche thing going on.
Appointment of Sir Roger Scruton — House of Commons, 2018-11-12
Topic: Culture
Philip Thomas Hollobone (Conservative, Centre-right): I congratulate the Government on attracting a world-leading expert in architectural aesthetics to this position, and I thank Sir Roger for accepting unpaid public service. Will the Secretary of State join me in deploring the Opposition’s tactics which seem to be based on soundbite misquotations generated on social media?
Finance (No. 3) Bill — House of Commons, 2018-11-12
Topic: Health
Alexander John Gervase Chalk (Conservative, Centre-right): It is critically important that we do not have a cap for those people who want to become nurses. One thing I found very depressing when I was first elected back in 2015 was that people wrote to me saying, "I want to become a nurse, but I can’t become a nurse, and yet the trust is off taking trips to other parts of the world to recruit nurses from overseas, while I cannot do it here in the UK." That is something that we should not allow to continue. It is important that the money is spent in the communities that require it. In Cheltenham at the moment, trust managers want to shift all general surgery facilities from Cheltenham to Gloucester, but, as 58 clinicians wrote only today, that would be a mistake. It would be unsatisfactory for care in the whole of Gloucestershire, and I am calling on the trust to think again There was also £400 million for potholes, which is a priority for my constituents and something that I take very seriously as well. That is an extra £8 million or so for Gloucestershire. I also welcome the measures to safeguard businesses in our high streets. We all know that they are facing increased pressures, but to take a third off the business rate bill of small businesses in my constituency is a shot in the arm for our high streets and is something of which we can be proud. When I went round high streets in Cheltenham over the weekend, the news from the Chancellor was welcomed. Businesses could look towards a future with real optimism. The scope to roll out these measures is only provided by managing the economy fairly and sensibly. We do not take measures simply because we take some pleasure in eradicating the deficit for the sake of it; we do so because we want to create opportunity in our society. We want to say to our young people, "Be brave and be bold about the future because it is an exciting future." A country that loses control of its finances loses control of the prospects of its young people. That is why I take pride in what the Chancellor has delivered and why we can say in confidence across this House that the United Kingdom’s best days lie ahead.
Finance (No. 3) Bill — House of Commons, 2018-11-12
Topic: Health
Stephen Charles Kerr (Conservative, Centre-right): The hon. Gentleman is quite right. Reference has already been made to the KPMG report, which was provided at the instigation of the Association of British Bookmakers. KPMG itself advised that that report "should not therefore be regarded as suitable to be used or relied on by any other person or for any other purpose" because its terms and scope were determined by KPMG’s client, the Association of British Bookmakers. Paddy Power Betfair wrote to the Prime Minister because it was so shocked that the report could be used as a credible source for decision making, saying that some of the assumptions in it were unrealistic Overcoming addiction is not simply a matter of exercising willpower. Addiction robs people of the power to decide for themselves. We in this House have the power to take the necessary measures that will protect the most vulnerable people, the most vulnerable families and the children of those families. I very much hope that the Government will take the decision to do that earlier.
Foreign Fighters and the Death Penalty — House of Commons, 2018-10-11
Topic: Defense
Philip Thomas Hollobone (Conservative, Centre-right): My constituents in Kettering are as outraged as I am that 900 British citizens should have decided to go abroad and become foreign fighters engaged in armed conflict against members of Her Majesty’s armed forces; 180 have been killed in theatre, 360 have returned and 360 remain at large. Why on earth are we not stripping these people of their British citizenship, not allowing them back into the country or, if they are allowed back in, trying them for treason?
Topical Questions — House of Commons, 2018-06-18
Topic: Culture
Questions: My constituent Shirley Todd, a wheelchair user, carried out a survey of part of the city and discovered that 72% of businesses were inaccessible to wheelchair users. She has now launched a national campaign and petition. Will the Minister agree to consider plans to make local authorities responsible for proactively enforcing the provisions in the Equality Act 2010?; Local councils in Northamptonshire today launched their official five-week consultation on how the eight councils in the county might best be merged into two by 2020. Will the Secretary of State join me in encouraging all local residents to take part so that their views can be heard loud and clear?; Houses in multiple occupancy are an important part of a mixed housing economy, but when whole streets of former family properties become HMOs, it can put great pressure on local services and leave remaining residents feeling isolated. What actions does the Secretary of State intend to take to genuinely empower local residents to have a meaningful influence on their communities where traditional planning requirements do not apply?; Chelmsford is a rapidly growing city, with many new houses planned, but plans for a second railway station and bypass have been put off for too many years. Fortunately, we are through to the final round of bids for the housing infrastructure fund. Will the Minister update us on the timing and process for Chelmsford’s key bids?; My right hon. Friend the Secretary of State will be aware of my view—as he and I have discussed it—that most objections to large planning developments are based on the fact that the developments themselves add nothing to the local vernacular, do not acknowledge it and are often poorly built. That is partly owing to a lack of local planning officers and the fact that planning officers are poorly trained. Could the Government consider affiliating some of them to the Royal Institute of British Architects or the Commission for Architecture and the Built Environment, and empowering them so that they can stand against the volume house builders?
Nigel Adams (Conservative, Centre-right): I thank the right hon. Gentleman for the fabulous work he has done, alongside UK Music and others interested in this subject, to bring about this change in policy in what is a very important area. The Government will be responding very shortly.
Topical Questions — House of Commons, 2018-06-18
Topic: Health
Questions: My constituent Shirley Todd, a wheelchair user, carried out a survey of part of the city and discovered that 72% of businesses were inaccessible to wheelchair users. She has now launched a national campaign and petition. Will the Minister agree to consider plans to make local authorities responsible for proactively enforcing the provisions in the Equality Act 2010?; Local councils in Northamptonshire today launched their official five-week consultation on how the eight councils in the county might best be merged into two by 2020. Will the Secretary of State join me in encouraging all local residents to take part so that their views can be heard loud and clear?; Houses in multiple occupancy are an important part of a mixed housing economy, but when whole streets of former family properties become HMOs, it can put great pressure on local services and leave remaining residents feeling isolated. What actions does the Secretary of State intend to take to genuinely empower local residents to have a meaningful influence on their communities where traditional planning requirements do not apply?; Chelmsford is a rapidly growing city, with many new houses planned, but plans for a second railway station and bypass have been put off for too many years. Fortunately, we are through to the final round of bids for the housing infrastructure fund. Will the Minister update us on the timing and process for Chelmsford’s key bids?; My right hon. Friend the Secretary of State will be aware of my view—as he and I have discussed it—that most objections to large planning developments are based on the fact that the developments themselves add nothing to the local vernacular, do not acknowledge it and are often poorly built. That is partly owing to a lack of local planning officers and the fact that planning officers are poorly trained. Could the Government consider affiliating some of them to the Royal Institute of British Architects or the Commission for Architecture and the Built Environment, and empowering them so that they can stand against the volume house builders?
Rishi Sunak (Conservative, Centre-right): The public health grant is not being ended; it is being folded into the business rates retention plan that the local government sector has welcomed and agreed for that process. Also, a new funding formula is being worked out with the Department of Health and Social Care specifically for public health, and I am sure we will welcome the hon. Lady’s contributions to that.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Nicholas Richard Hurd (Conservative, Centre-right): Over the weekend, my right hon. Friend the Home Secretary issued an emergency licence to allow Billy Caldwell’s medical team to access cannabis-based medicine. This was an emergency procedure, led by a senior clinician with the support of the medical director at Chelsea and Westminster Hospital. I am sure that the whole House will want to join me in expressing genuine concern for Billy’s health, and that they will be pleased with the news that he has been discharged from hospital today The course of action in this case was unprecedented. I should explain that our guiding principle is that any process in this context must be clinically led and evidence based. To date, Home Office policy has been to permit the production, supply and possession of raw cannabis solely for research purposes under a Home Office licence. The cannabis-based medicine Sativex is currently the only one that can be prescribed in the UK, because there is a proven case for its safety and efficacy. However, this case and that of Alfie Dingley and others have shone a light on the use of cannabis-based medicine in this country and highlighted the need for the Government to explore the issue, and our handling of these issues, further I recognise the need to ensure that the approach to licensing works more effectively. As a first step, I can announce today that the Government are establishing an expert panel of clinicians to advise Ministers on any individual applications to prescribe cannabis-based medicines. This is consistent with the principle that a clinician must be at the heart of the process. I have asked Dame Sally Davies to take forward this important work. Let me be clear that both the Home Secretary and I have, as fathers, been profoundly moved by Billy’s story and others like it, along with the rest of the House and the rest of the country. I want to reassure the families and the public that the Home Secretary and I are working together to do all we can to take forward the necessary steps at pace, and that more announcements will be forthcoming.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Nicholas Richard Hurd (Conservative, Centre-right): I thank the hon. Lady for that long list of questions, and I will do my best to answer them. She asked about the recognition of the medical benefits of some cannabis-based medicine but, as I said in my response, they are already recognised by the fact that, for example, Sativex can be prescribed in the UK. Its safety and efficacy have been proven, and it has been rigorously tested. She will know the responsibility of the Government and everyone involved in the process to ensure that medicines are safe, but the system allows for medicines to be licensed once they are established and tested The hon. Lady mentioned the case of Alfie Dingley, with which I am familiar, and I made it clear that, however we may feel about the current rules, I undertook to try to find a solution for Alfie within the existing rules. Again, it is an unprecedented situation, because this is the first time that we are considering a personal licence, so this is new ground for everyone. I can confirm to her, as I confirmed to the family, that the process of applying for a licence to find a long-term sustainable legal solution for Alfie is well under way. It is clinically led, and I have given assurances that we will drive the process as hard as possible. Indeed, a date has been set for a compliance visit, which is a necessary part of the process. We are pushing things as hard as possible, and I want to place on the record my thanks, appreciation and respect for the dignity and patience of Alfie’s family in this difficult situation The hon. Lady challenges the Government to change fast, and I think I have made it clear that, as the Prime Minister said this morning, we have to look hard at our processes for handling such situations. We must ensure, as the Health Secretary made clear today, that our policy is fully up to date with the best possible understanding of the most recent and relevant evidence. As I am sure the hon. Lady will appreciate, the Government have to take a bit of time to think things through. We have to get the detail right. We do not have the luxury of opposition; we have to work through the detail to get this right. My statement recognises not only that we are taking immediate steps to improve our processes so that they become more clinically led, with the introduction of a new clinically-led panel of experts to advise Ministers, but that we are taking a wider look at policy processes and will be making a forthcoming announcement.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
George Iain Duncan Smith (Conservative, Centre-right): I welcome my right hon. Friend’s statement. I am by no means a supporter of recreational cannabis use. However, a woman I know, Amelia Powers, was given two weeks to live with a diagnosis of a tumour of the brain. There was nothing more they could do, and she took to using a form of this and, for the last seven or eight years, has not just reduced the tumour but has got rid of it. She now runs her own company, which she started The point I would make is somewhat wider. The biggest problem the Minister faces is that in the Department of Health and Social Care it is still not considered a good thing to investigate the medicinal properties of this particular drug. I urge him, if at all possible, to try to get a coalition on getting this investigated, because clearly there are medicinal preparations that could be used. It would be helpful if he drove that.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Nicholas Richard Hurd (Conservative, Centre-right): I suspect that every Member has personal knowledge, directly or indirectly, of people who swear by the benefits of cannabis-based medicine that has helped them in very difficult circumstances. I completely understand that My right hon. Friend talked about building a coalition across Government on updating the evidence, and I signalled in my statement that that is exactly what is happening. The Under-Secretary of State for Health and Social Care, my hon. Friend the Member for Winchester (Steve Brine), is sitting alongside me, and I refer my right hon. Friend the Member for Chingford and Woodford Green (Mr Duncan Smith) to this morning’s comments by the Secretary of State for Health and Social Care, which make it clear that the Government are seriously looking again at our processes and how we handle these cases.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Caroline Elizabeth Johnson (Conservative, Centre-right): I refer Members to my declaration of interest, as a consultant paediatrician. Some compounds within cannabis have anticonvulsive properties. Cannabidiol has been shown in animal studies to have an active anticonvulsant compound, but THC, the one that is illegal in certain concentrations, has been found to have both anticonvulsant and proconvulsant properties in animal studies, and there are concerns that it may also be responsible for causing significant psychological problems, such as psychosis, if used over a longer period. Epidiolex is a pharmaceutical grade, quality-assured product that contains cannabidiol but less than 0.1% THC, and it is both legal and used in clinical trials in this country, including with children. The oils available on the internet or at health food shops are not subject to that sort of scrutiny, do not have the same level of quality assurance and have variable levels of concentrations. Does my right hon. Friend agree that there is a huge difference between these two products—the quality-assured one and the not quality-assured one—and that we need to investigate the best possible scientific evidence on the usage and benefits of cannabis-based medicines, so that they can be used safely and properly to the best effect for our patients?
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Nicholas Richard Hurd (Conservative, Centre-right): I defer to my hon. Friend’s medical knowledge, and her intervention just reinforces the point I am trying to make about the need for this process to be clinically led, as far as is possible. She is making the point about there being certain cannabis medicines and certain conditions, and the evidence is at best mixed on this. She makes the fundamental point about our responsibility, as regulators, being to make sure that people are accessing and using products that are tried and tested, and as safe as possible. Let us imagine the consequences of prescribing an unregulated medicine that goes wrong—imagine the scene in this House at that point. In our, understandably, emotional response to recent events, we must also make sure that we do policy right and get it right. That is why we require a little more time to come back to this House with more detailed plans.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Julian Murray Lewis (Conservative, Centre-right): Does my right hon. Friend accept that there is nothing new, and no inherent contradiction, in having available for medicinal use addictive drugs that one would not allow for recreational use? May I illustrate that by describing my personal experience of 32 years ago? When recovering from severe back surgery, I was given a rather pleasant drug and I asked for a repeat prescription, only to be told that as morphia is related to heroin, there were limits on how much they were going to give me. So why can common sense not prevail in the case of marijuana, as occurred in that case?
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Antoinette Geraldine Sherratt (Sandbach) (Conservative, Centre-right): My constituent’s two-and-a-half-year-old son was having 300 seizures a day. He described each one as resetting his son’s brain like a computer hard drive being wiped. Following the use of CBD, the seizures have been reduced to between 30 and 50 a day. Will the Minister meet me to discuss this case, and will he perhaps meet my constituent, because he has an outstanding application for a medical licence for his son?
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Nicholas Richard Hurd (Conservative, Centre-right): I can certainly give my hon. Friend that assurance. I will of course offer to meet her constituent, as I have met every single family who have come forward, because we are absolutely serious about trying to help, as far as we can, because these cases are deeply difficult. I come back, though, to the point that I am sure my hon. Friend will absolutely respect, which is that it should not really be down to politicians to make these decisions; it has to be a clinically led process. When the clinicians came forward this week on Billy’s behalf, we were able to respond to the request for emergency help, but it has to be a clinically led process.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Nicholas Richard Hurd (Conservative, Centre-right): The evidence base comes from the official advice from the advisory council and others and it has been set for some time. The rules that we are having to work with have been around for a while under successive Governments. If this is the moment to revisit and challenge those rules, that is the role of a parliamentary democracy. What I am saying is that the Government have reflected deeply on the events of the past few weeks. They are constantly updating the evidence from the World Health Organisation and others, and are actively discussing changes to the way in which we handle these cases. I have made one announcement today and expect others to follow.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Crispin Jeremy Rupert Blunt (Conservative, Centre-right): I thank my right hon. Friend for the way in which he personally intervened on Friday afternoon as the deterioration in Billy Caldwell’s condition became clear, and the Home Secretary for his response within hours of his becoming aware of the situation. My right hon. Friend knows that he has received advice from me, as co-chair of the all-party group for drug policy reform, about how the Government should navigate their way out of this. I offer to assist in the review that is going on. Will he also take advice from Charlotte Caldwell, whom I have met a number of times before this week? She is a redoubtable campaigner and, of necessity, an expert in this field. I hope that he will take up her offer of engaging with her in this process Finally, I do have an anxiety that the framework of this review, if it is within the current law, could end up with the wrong answer. The problem is that the current law is based on the wrong premise, which is that there is no value in this medicine.
Medicinal Cannabis — House of Commons, 2018-06-18
Topic: Health
Nicholas Richard Hurd (Conservative, Centre-right): The advisory council’s advice on the lack of evidence around the medicinal benefits of cannabis and cannabis-based medicines has not changed, but the process needs to be reviewed constantly in the light of the evidence, and that is what we do. I should clarify that the clinical panel that I have announced today will advise Ministers on specific claims and applications that come to us.